• 4basebio shareholders passed all resolutions at the November 6, 2026 general meeting, authorizing directors to allot shares for the capital raise.
• Shareholders also approved disapplying pre-emption rights for those allotments.
• Admission of 485,436 VCT Placing Shares is scheduled for November 9, 2026.
• Admission of 3,210,774 Non-VCT Placing Shares, Subscription Shares and Retail Offer Shares is scheduled for November 10, 2026.
• Completion remains conditional on both admissions and the Placing Agreement becoming unconditional without termination before the November 10 admission.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4BASEBIO plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611060745PR_NEWS_PRUKDSCX_0074) on November 06, 2026, and is solely responsible for the information contained therein.